Literature DB >> 11713823

DNA vaccines: capacity to induce auto-immunity and tolerance.

D M Klinman1, F Takeshita, S Kamstrup, S Takeshita, K Ishii, M Ichino, H Yamada.   

Abstract

DNA technology has facilitated the development of plasmid-based vaccines designed to prevent viral, bacterial and parasitic infections. The rapid transition of these novel vaccines from the laboratory to the clinic raises important safety concerns. Our review examines whether DNA vaccines (i) are likely to induce systemic or organ-specific auto-immune disease and (ii) have the potential to induce tolerance rather than immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11713823

Source DB:  PubMed          Journal:  Dev Biol (Basel)        ISSN: 1424-6074


  8 in total

Review 1.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

2.  Vaccines against Toxoplasma gondii: status, challenges and future directions.

Authors:  Qi Liu; Lachhman Das Singla; Huaiyu Zhou
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

Review 3.  FDA guidance on prophylactic DNA vaccines: analysis and recommendations.

Authors:  Dennis M Klinman; Sven Klaschik; Debra Tross; Hidekazu Shirota; Folkert Steinhagen
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

Review 4.  DNA vaccines: ready for prime time?

Authors:  Michele A Kutzler; David B Weiner
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

Review 5.  Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.

Authors:  Seleeke Flingai; Matias Czerwonko; Jonathan Goodman; Sagar B Kudchodkar; Kar Muthumani; David B Weiner
Journal:  Front Immunol       Date:  2013-11-04       Impact factor: 7.561

6.  Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice.

Authors:  Zahra Abdossamadi; Negar Seyed; Farnaz Zahedifard; Tahereh Taheri; Yasaman Taslimi; Hossein Montakhab-Yeganeh; Alireza Badirzadeh; Mohammad Vasei; Safoora Gharibzadeh; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2017-12-18

7.  Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy.

Authors:  Seleeke Flingai; Emily M Plummer; Ami Patel; Sujan Shresta; Janess M Mendoza; Kate E Broderick; Niranjan Y Sardesai; Kar Muthumani; David B Weiner
Journal:  Sci Rep       Date:  2015-07-29       Impact factor: 4.379

Review 8.  Therapeutic Vaccine Strategies against Human Papillomavirus.

Authors:  Hadeel Khallouf; Agnieszka K Grabowska; Angelika B Riemer
Journal:  Vaccines (Basel)       Date:  2014-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.